PMID- 30267995 OWN - NLM STAT- MEDLINE DCOM- 20191003 LR - 20191007 IS - 1872-8421 (Electronic) IS - 0165-5728 (Linking) VI - 324 DP - 2018 Nov 15 TI - 1,25-Dihydroxyvitamin D(3) increases the methionine cycle, CD4(+) T cell DNA methylation and Helios(+)Foxp3(+) T regulatory cells to reverse autoimmune neurodegenerative disease. PG - 100-114 LID - S0165-5728(18)30224-8 [pii] LID - 10.1016/j.jneuroim.2018.09.008 [doi] AB - We investigated how one calcitriol dose plus vitamin D(3) reverses experimental autoimmune encephalomyelitis (EAE), a multiple sclerosis model. This protocol rapidly increased CD4(+) T cell Ikzf2 transcripts, Helios protein, and CD4(+)Helios(+)FoxP3(+) T regulatory cells. It also rapidly increased CD4(+) T cell Bhmt1 transcripts, betaine:homocysteine methyltransferase-1 (BHMT1) enzyme activity, and global DNA methylation. BHMT1 transmethylates homocysteine to replenish methionine. Targeting the Vdr gene in T cells decreased Ikzf2 and Bhmt1 gene expression, reduced DNA methylation, and elevated systemic homocysteine in mice with EAE. We hypothesize that calcitriol drives a transition from encephalitogenic CD4(+) T cell to Treg cell dominance by upregulating Ikzf2 and Bhmt1, recycling homocysteine to methionine, reducing homocysteine toxicity, maintaining DNA methylation, and stabilizing CD4(+)Helios(+)FoxP3(+)Tregulatory cells. Conserved vitamin D-responsive element (VDRE)-type sequences in the Bhmt1 and Ikzf2 promoters, the universal need for methionine in epigenetic regulation, and betaine's protective effects in MTHFR-deficiency suggest similar regulatory mechanisms exist in humans. CI - Copyright (c) 2018 Elsevier B.V. All rights reserved. FAU - Moore, Jerott R AU - Moore JR AD - Department of Biochemistry, College of Agricultural and Life Sciences, University of Wisconsin-Madison, 433 Babcock Drive, Madison, WI 53706, United States. FAU - Hubler, Shane L AU - Hubler SL AD - Rhapsody Data, LLC, Madison, WI 53705, United States. FAU - Nelson, Corwin D AU - Nelson CD AD - Department of Animal Sciences, University of Florida, Gainesville, FL 32611, United States. FAU - Nashold, Faye E AU - Nashold FE AD - Department of Biochemistry, College of Agricultural and Life Sciences, University of Wisconsin-Madison, 433 Babcock Drive, Madison, WI 53706, United States. FAU - Spanier, Justin A AU - Spanier JA AD - Rheumatic and Autoimmune Diseases, Center for Immunology, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, United States. Electronic address: span0005@umn.edu. FAU - Hayes, Colleen E AU - Hayes CE AD - Department of Biochemistry, College of Agricultural and Life Sciences, University of Wisconsin-Madison, 433 Babcock Drive, Madison, WI 53706, United States. Electronic address: hayes@biochem.wisc.edu. LA - eng GR - P30 CA014520/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20180921 PL - Netherlands TA - J Neuroimmunol JT - Journal of neuroimmunology JID - 8109498 RN - 0 (DNA-Binding Proteins) RN - 0 (Forkhead Transcription Factors) RN - 0 (Foxp3 protein, mouse) RN - 0 (Transcription Factors) RN - 0 (Zfpn1a2 protein, mouse) RN - 1406-16-2 (Vitamin D) RN - 66772-14-3 (1,25-dihydroxyvitamin D) RN - AE28F7PNPL (Methionine) RN - FXC9231JVH (Calcitriol) SB - IM MH - Animals MH - CD4-Positive T-Lymphocytes/*drug effects/immunology/metabolism MH - Calcitriol/pharmacology/therapeutic use MH - Cells, Cultured MH - DNA Methylation/*drug effects/physiology MH - DNA-Binding Proteins/immunology/metabolism MH - Encephalomyelitis, Autoimmune, Experimental/*drug therapy/immunology/metabolism MH - Female MH - Forkhead Transcription Factors/immunology/metabolism MH - Male MH - Methionine/*agonists/metabolism MH - Mice MH - Mice, Inbred C57BL MH - Mice, Transgenic MH - Neurodegenerative Diseases/drug therapy/immunology/metabolism MH - T-Lymphocytes, Regulatory/*drug effects/immunology/metabolism MH - Transcription Factors/immunology/metabolism MH - Vitamin D/*analogs & derivatives/pharmacology/therapeutic use EDAT- 2018/09/30 06:00 MHDA- 2019/10/08 06:00 CRDT- 2018/09/30 06:00 PHST- 2018/04/28 00:00 [received] PHST- 2018/09/12 00:00 [revised] PHST- 2018/09/18 00:00 [accepted] PHST- 2018/09/30 06:00 [pubmed] PHST- 2019/10/08 06:00 [medline] PHST- 2018/09/30 06:00 [entrez] AID - S0165-5728(18)30224-8 [pii] AID - 10.1016/j.jneuroim.2018.09.008 [doi] PST - ppublish SO - J Neuroimmunol. 2018 Nov 15;324:100-114. doi: 10.1016/j.jneuroim.2018.09.008. Epub 2018 Sep 21.